FIELD: medicine.
SUBSTANCE: invention relates to molecular biology and can be used to increase efficiency and targeted selectivity of effect on tumour cells using radiation exposure. Method for radiosensitization of tumour cells involves exposing a tumour cell to a substance which is a glycolysis inhibitor and simultaneously blocks cell proliferation, which is represented by glucosamine D hydrochloride in concentration of 10 mM.
EFFECT: invention provides higher radiosensitization and targeted selectivity of tumour cell exposure without affecting non-tumour cells by blocking cell proliferation in the radio-sensitive G1 phase of the cell cycle.
1 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION INHIBITING TUMOR GROWTH AND SURVIVAL RATE | 2019 |
|
RU2707554C1 |
| N,N'-HYDRAZINO-BIS-ISATIN DERIVATIVES WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2796559C1 |
| METHOD FOR PROCESSING TUMOUR CELLS | 2016 |
|
RU2632429C1 |
| METHOD FOR NON-CONTACT STIMULATION OF TRANSCRIPTIONAL ACTIVITY OF CYCLIN-DEPENDENT KINASE 2 INHIBITOR GENE IN PROSTATE TUMOR CELLS | 2020 |
|
RU2763992C1 |
| METHOD FOR INCREASING THE FREQUENCY OF FORMATION OF DOUBLE-STRAND BREAKS OF DNA IN HUMAN CELLS UNDER ACTION OF IONIZING RADIATIONS UNDER CONDITIONS OF RADIO MODIFIERS | 2018 |
|
RU2699670C1 |
| METHOD FOR INCREASING THE EFFECTIVENESS OF IONIZING RADIATION ON MELANOMA | 2021 |
|
RU2774032C1 |
| ANTICANCER COMPOSITION | 2019 |
|
RU2789245C2 |
| BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
| THERAPEUTIC APPLICATION OF YESSOTOXINS AS INHIBITORS OF HUMAN TUMOUR CELL GROWTH | 2004 |
|
RU2389488C2 |
| TREATING PANCREATIC CANCER AND NON-SMALL CELL LUNG CANCER WITH ATR INHIBITORS | 2012 |
|
RU2648507C2 |
